Bubonic plague cases affirmed in China, specialists recommend danger of pestilence Kumar Jeetendra | July 7, 2020 The thing that was the world’s most feared disorder is straight back again due of china. By COVID-19, to Swine influenza and the Bubonic plague. The city of Bayannur in inner Mongolia could be the epicentre of that which may possibly be still another outbreak. China’s debateable health and creature exchange has risked the lives …
Protein delivered by the human safe framework can emphatically hinder Sars-Cov-2 Kumar Jeetendra | August 3, 2020 A protein produced by the human immune system may strongly inhibit corona viruses, including Sars-Cov-2, the pathogen causing Covid-19. An international team from Germany, Switzerland and the USA successfully showed the LY6E-Protein prevents coronaviruses from causing the illness. “This finding may result in the development of new therapeutic approaches against coronaviruses,” says Professor Stephanie Pfänder …
AnteoTech’s COVID-19 antigen and Flu A&B test distinguishes SARS-Cov-2, flu in under 15 minutes Kumar Jeetendra | August 23, 2020 AnteoTech Ltd has developed proof-of-concept COVID-19 antigen and Flu A&B point-of-care lateral flow tests which could detect the existence of SARS-Cov-2 and influenza in under 15 minutes. The tests utilize AnteoTech’s patented AnteoBind™ activated europium technologies and provide considerably higher sensitivity than that provided by currently available COVID-19 tests. AnteoTech intends for the tests to …
The Native Antigen Company declares custom agreement administration to create flu An and B antigens Kumar Jeetendra | August 23, 2020 The Native Antigen Company (now part of LGC’s Clinical Diagnostics Division), among the world’s leading suppliers of reagents which enables research into vaccines and diagnostics for emerging and endemic infectious diseases, today announced the debut of its custom contract agency to rapidly develop antigen panels for influenza A and B viruses. This new service provides …
Flu antibody doesn’t expand COVID-19 danger: Study Kumar Jeetendra | September 22, 2020 Receiving the influenza vaccine does not increase a person’s risk for contracting COVID-19 or aggravate related conditions or mortality, according to a study. The study, published in the Journal of Clinical and Translational Science, shows the flu vaccine is the single most important intervention to help stay healthy. Seasonal flu activity is unpredictable, and healthy …
New T-cell-based immunization procedure gives more extensive insurance against occasional flu Kumar Jeetendra | September 24, 2020 As Americans begin pulling their sleeves up for an annual flu vaccine, researchers at the University of Wisconsin-Madison have provided new insights into an alternate vaccine approach that provides wider protection against seasonal flu. In a study published in Cell Reports Medicine today (Sept. 22), scientists describe a T-cell-based vaccine strategy that’s effective against multiple …
Yale assigns three free research facilities to perform SalivaDirect COVID-19 test Kumar Jeetendra | September 26, 2020 Laboratory evaluations of surgical and N95 masks by researchers at the University of California, Davis, show that they do cut down the amount of aerosolized particles generated during breathing, coughing and talking. Tests of homemade fabric face coverings, however, show that the fabric itself releases a large amount of fibers to the air, underscoring the …
Parkinson’s disease is a free danger factor for biting the dust from COVID-19, study recommends Kumar Jeetendra | October 3, 2020 A fresh study of about 80,000 patients shows that people with Parkinson’s disease (PD) have a 30% greater risk of dying from COVID-19 than individuals without the neurodegenerative condition. The new analysis conducted by researchers at University of Iowa Health Care based on patient information in the TriNetX COVID-19 research network suggests that Parkinson’s disease …
Researchers devise new technique to plan HIV’s sweet shield in remarkable detail Kumar Jeetendra | October 26, 2020 Scientists from Scripps Research and Los Alamos National Laboratory have devised a method for mapping in unprecedented detail the thickets of slippery sugar molecules which help protect HIV from the immune system. Mapping these shields will give researchers a more comprehensive comprehension of why dinosaurs respond to some spots on the virus but not others, …
Researchers give knowledge on how lung microorganisms secure against attacking microbes Kumar Jeetendra | December 9, 2020 New insight on how bacteria in the lungs protect against invading pathogens has been published today in the open-access eLife journal. The study in mice shows that a strain of lung bacteria called Lactobacillus provides a barrier against Streptococcus pneumoniae (S. pneumoniae) colonisation in animals previously infected with influenza A virus when applied therapeutically following …
IGC analysts get three out of six European Research Council grants Kumar Jeetendra | December 11, 2020 Since the establishment of the European Research Council in 2008, the IGC has secured 17 of the competitive grants (7 Beginning, 8 Consolidator and two Advanced). In 2021, with the beginning of the new grants awarded this month, it will have ten active grants. The year of 2020 marks a total of 327 researchers chosen …
Researchers arrive at significant achievement in leishmaniasis immunization advancement Kumar Jeetendra | January 11, 2021 Scientists have taken an important step forward in creating a controlled human infection model to test leishmaniasis vaccines. The University of York-led study identified and characterized a new strain of Leishmania parasite that will form the basis of a new controlled human infection model for the disease which is transmitted by the bite of sand …
